跳至主要内容
临床试验/NCT07531420
NCT07531420已完成不适用

Impact of Antibiotic Prophylaxis Modification on Surgical Site Infections Following Pancreaticoduodenectomy: The Role of Local Microbiological Ecology (ICADI Study)

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
117
试验地点
1
主要终点
Surgical Site Infection rate within 30 days after pancreaticoduodenectomy

研究概览

简要总结

Patients undergoing pancreaticoduodenectomy after preoperative biliary drainage are at increased risk of surgical site infections (SSI) due to bile colonization. Recent guidelines recommend the use of piperacillin/tazobactam instead of cephalosporins for antibiotic prophylaxis in this population. However, the relevance of this strategy may depend on local microbiological ecology.

This monocentric ambispective cohort study aims to compare SSI rates between two periods: before and after implementation of piperacillin/tazobactam prophylaxis. The study also evaluates microbiological profiles of bile cultures, antibiotic susceptibility, and postoperative antibiotic exposure.

The primary hypothesis is that adaptation of antibiotic prophylaxis to local ecology may optimize outcomes while limiting unnecessary exposure to broad-spectrum antibiotics.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (> 18 yrs)
  • Scheduled for pancreatic surgery
  • Presence of preoperative biliary stent
  • Postoperative admission to surgical ICU or intermediate care unit

排除标准

  • decline to participate

研究组 & 干预措施

Period 1 (2022 - 2023)

Adult patients scheduled for pancreatic surgery receiving cefazolin as antibiotic prophylaxis

Period 2 (2024 - 202()

Adult patients scheduled for pancreatic surgery receiving piperacillin/taazobactam as antibiotic prophylaxis

结局指标

主要结局

Surgical Site Infection rate within 30 days after pancreaticoduodenectomy

时间窗: Day 30

次要结局

  • Pancreatic fistula rate within 30 days after pancreaticoduodenectomy(Day 30)
  • Postoperative carbapenem exposure(Day 30)
  • Proportion of bacteria susceptible to cephalosporins and piperacillin/tazobactam(Day 1)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验